Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : NBMX - National Boston Medical (was FGRX) -- Ignore unavailable to you. Want to Upgrade?

To: Don who wrote (263)	10/20/1998 10:22:00 AM
From: xbrent	Read Replies (2) \| Respond to of 1286

FGRX has given some clues as to their potential. The acquisition with National Boston, the symbol change, the book value/audit, annual sales of the new company, probable acquistion (s) within the month. 80 mfr reps presently being trained to sell the Bontempi line of medical tools. National Boston presently updating website with complete line of products including Bontempi. Boston National is exclusive agent for their tools outside of Europe. FGRX will undoubtedly issue multiple press releases thru their agent Baron Marney. Baron Marney usually issues releases between 10 am and noon. I have no idea as to the sequence of the press releases or their impact on the overall market. We should see some info this week probably a number of press releases. Should see some releases right thru end of the month. I think that the book value/audit results will be explosive if in fact the company is worth $3 in hard assets. The market should respond to top line sales of $40 million for Boston National/Fragrance. Some press releases will probably have little impact on the stock while others should move it considerably. But with a BB stock anything which significantly contributes to overall viability of the company should help to reassure investors.